TIMOTHY SOUCHEK: Open Payments
NPI 1194709881 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 20 payments from 10 companies in 2025. Trend: 2023 $3,750 · 2024 $4,429 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $119 |
| BeOne Medicines USA, Inc. | 3 | $94 |
| Daiichi Sankyo Inc. | 3 | $68 |
| GlaxoSmithKline, LLC. | 2 | $63 |
| PFIZER INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Rigel Pharmaceuticals, Inc. | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $26 |
| PharmaEssentia USA Corporation | 1 | $19 |
| ARRAY BIOPHARMA INC | 1 | $19 |
Products named: PLUVICTO, BRUKINSA, Enhertu, ELREXFIO, CALQUENCE, JEMPERLI, OJJAARA, TAVALISSE.
Industry payments across CA — which companies pay providers there.
